SHPH
Shuttle Pharmaceuticals Holding
$3.76
+1.35%
2026-08-21
About Shuttle Pharmaceuticals Holding
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Key Fundamentals
P/E Ratio
40.70
EPS (TTM)
$0.10
ROE
-326.4%
Profit Margin
0.0%
Debt/Equity
6.40
Price/Book
0.68
Beta
1.22
Market Cap
$2.4M
Avg Volume (10D)
225K
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$6.15
60D Low
$0.38
Avg Volume
2.1M
Latest Close
$3.76
Get breakout alerts for SHPH
Sign up for Breakout Scanner to receive daily notifications when SHPH triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
Shuttle Pharmaceuticals Holding (SHPH) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors SHPH daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. SHPH operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry. Data is provided for informational purposes only and does not constitute financial advice.